“Characterizing Deep Quality-of-Life Response in the TRuE-V1 TRuE-V2 Studies of Ruxolitinib Cream in Nonsegmental Vitiligo”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s752, https://doi.org/10.25251/bpnxm492.